Citizens JMP’s $24 target on KURA

KURA Kura Oncology Inc

$9.83 → $24 (+144%) by Oct 2027

Market Outperform · reiterates · said Oct 14, 2026 · 12-month default horizon

Open: judged on the close on Oct 14, 2027

The article this target came from

Citizens reiterates Kura Oncology stock rating on diabetes data

Investing.com · Oct 14, 2026

Citizens reiterated a Market Outperform rating and $24.00 price target on Kura Oncology

Citizens JMP’s track record → Kura Oncology Inc →

A fact about what Citizens JMP published, as reported by Investing.com, not a recommendation from Dalsna Finance; Citizens JMP is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.